Signaling through the TGF beta-activin receptors ALK4/5/7 regulates testis formation and male germ cell development

PLoS One. 2013;8(1):e54606. doi: 10.1371/journal.pone.0054606. Epub 2013 Jan 16.

Abstract

The developing testis provides an environment that nurtures germ cell development, ultimately ensuring spermatogenesis and fertility. Impacts on this environment are considered to underlie aberrant germ cell development and formation of germ cell tumour precursors. The signaling events involved in testis formation and male fetal germ cell development remain largely unknown. Analysis of knockout mice lacking single Tgfβ family members has indicated that Tgfβ's are not required for sex determination. However, due to functional redundancy, it is possible that additional functions for these ligands in gonad development remain to be discovered. Using FACS purified gonadal cells, in this study we show that the genes encoding Activin's, TGFβ's, Nodal and their respective receptors, are expressed in sex and cell type specific patterns suggesting particular roles in testis and germ cell development. Inhibition of signaling through the receptors ALK4, ALK5 and ALK7, and ALK5 alone, demonstrated that TGFβ signaling is required for testis cord formation during the critical testis-determining period. We also show that signaling through the Activin/NODAL receptors, ALK4 and ALK7 is required for promoting differentiation of male germ cells and their entry into mitotic arrest. Finally, our data demonstrate that Nodal is specifically expressed in male germ cells and expression of the key pluripotency gene, Nanog was significantly reduced when signaling through ALK4/5/7 was blocked. Our strategy of inhibiting multiple Activin/NODAL/TGFβ receptors reduces the functional redundancy between these signaling pathways, thereby revealing new and essential roles for TGFβ and Activin signaling during testis formation and male germ cell development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activin Receptors, Type I / genetics
  • Activin Receptors, Type I / metabolism*
  • Animals
  • Fluorescent Antibody Technique
  • Germ Cells / cytology*
  • Germ Cells / metabolism
  • Immunoblotting
  • Male
  • Mice
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Receptor, Transforming Growth Factor-beta Type I
  • Receptors, Transforming Growth Factor beta / genetics
  • Receptors, Transforming Growth Factor beta / metabolism*
  • Signal Transduction / genetics
  • Signal Transduction / physiology
  • Testis / cytology*
  • Testis / metabolism*

Substances

  • Receptors, Transforming Growth Factor beta
  • Protein Serine-Threonine Kinases
  • Activin Receptors, Type I
  • Acvr1b protein, mouse
  • Acvr1c protein, mouse
  • Receptor, Transforming Growth Factor-beta Type I
  • Tgfbr1 protein, mouse

Grants and funding

This work was supported by funding from the Monash University Faculty of Medicine, Nursing and Health Sciences funding granted to PW, and the Victorian Government's Operational Infrastructure Support Program and ARC Centre of Excellence for Biotechnology and Development awarded to AHS. DM was supported by a Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria. DW is supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.